Drug Repurposing Presentation: Finding the therapeutic plausibility of a drug in any indication

To quote from a recent article by Seth Lederman, Co-Founder and CEO of Tonix Pharmaceuticals, "New markets for repurposed drugs could be the key to research and development productivity while products lose patent protection". It is safe to say that all those involved in drug discovery and development are seeking new opportunities and strategies to reduce the risk of drug …

Developing orphan drugs in Asia through successful collaboration – Orient Europharma

>Click here to download the presentation. Gain insight from Orient Europharma's presentation on developing orphan drugs in Asia through successful collaborative efforts between biotechs and policy makers. Learn about the differences in definition of orphan drugs between Western and Asian countries, the characteristics and thus challenges of the orphan market and understand from case studies certain key successful factors in …

How to overcome clinical development challenges for rare diseases in Asia – PharmAbcine

>Click here to download the presentation. Read about overcoming clinical development challenges for rare diseases in Asia as presented by PharmAbcine. Apart from learning about PharmAbcine and its history, understand what exactly orphan diseases are and see from examples such as Glioblastoma Multiforme (GBM) and Pancreatic Cancer in Korea. Furthermore, the basic components of clinical development barriers will be discussed, …

Rare disease in China – the role of the China Dolls Centre

>Click here to download the presentation. Learn about the current situation of rare disease patients and organisations in China from the China Dolls Centre for Rare Diseases. The different methods of medical aid and help for these patients will be discussed, along with the role of the China Dolls Centre and its goals in helping patients of rare diseases such …

The rare disease regulatory environment – University of Yamanashi, Japan

>Click here to download the presentation. The Department of Clinical Research from the University of Yamanashi, Japan presents on the regulatory environment of rare diseases and its challenges, successes as well as areas for optimisation. Understand the need to have urgency to act on rare diseases and its patients, and learn from trends in the orphan drug regulatory framework. In …

Bringing orphan drugs to Malaysia and Singapore – PharmD

>Click here to download the presentation. Learn from PharmD's presentation on its perspective from the Malaysia and Singapore Market on orphan drug imports. Learn about the legislation and registration of orphan drugs in Malaysia and Singapore as well as the challenges faced such as problems in funding treatment or the complexity of the supply chain. Gain insights from case studies …

Placing patients at the heart of Taiwan’s rare disease and orphan drug movement

>Click here to download the presentation. The Taiwan Foundation for Rare Disorders (TFRD) presents the importance of placing patients at the heart of the orphan drugs commercialisation. Learn about Taiwan's rare disease and orphan drug movement, the establishment of TRFD as well as the strategies TRFD takes to protect the rights and take care of rare disease patients and their …

Participation Announcement: Moorfields Pharmaceuticals confirmed to Exhibit at the World Orphan Drug Congress Europe 2013

It is with great pleasure to announce that Moorfields Pharmaceuticals will be exhibiting their experience and expertise at the 4th Annual World Orphan Drug Congress Europe in Geneva on the 14-15th November 2013. Part of the Moorfields Eye Hospital NHS Foundation Trust, Moorfields Pharmaceuticals specialises in niche and innovative pharmaceutical products. In recent years, Moorfields Pharmaceuticals have launched a range …

The role of government in ensuring orphan drug success in Korea – Korea Orphan Drug Centre

Read about the importance of the government in ensuring the success of orphan drugs in Korea as presented by the Korea Orphan Drug Centre (KODC). Apart from insights being given on rare diseases and the orphan drug system in Korea, the roles of government agencies along with the current efforts by the government for rare disease patients will be discussed. …